Performance of a cytomegalovirus IgG enzyme immunoassay kit modified to measure avidity

Clinical and Vaccine Immunology

Volumn 21, Issue 6, 2014, Pages 808-812

  Prince, Harry E ^a   Lapé Nixon, Mary ^a   Novak Weekley, Susan M ^b  

^a Focus Diagnostics   (United States)

^b Southern California Permanente Medical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN G; DIAGNOSTIC KIT; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; AVIDITY INDEX; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOMEGALOVIRUS IGG ENZYME IMMUNOASSAY KIT; DIAGNOSTIC KIT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MICROBIOLOGICAL PARAMETERS; MIDDLE AGED; PRIORITY JOURNAL; VALIDATION STUDY; VIRUS DETECTION; YOUNG ADULT; ANTIBODY AFFINITY; BLOOD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DEVICES; ENZYME IMMUNOASSAY; IMMUNOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROCEDURES;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REAGENT KITS, DIAGNOSTIC; YOUNG ADULT;

EID: 84901639909     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00105-14     Document Type: Article

References (26)

1. Bodéus M, Beulné D, Goubau P. 2001. Ability of three IgG-avidity assays to exclude recent cytomegalovirus infection. Eur. J. Clin. Microbiol. Infect. Dis. 20:248-252. http://dx.doi.org/10.1007/s100960100484. (Pubitemid 32477242)
2. Lazzarotto T, Spezzacatena P, Pradelli P, Abate DA, Varani S, Landini MP. 1997. Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. Clin. Diagn. Lab. Immunol. 4:469-473. (Pubitemid 27321782)
3. Lazzarotto T, Spezzacatena P, Varani S, Gabrielli L, Pradelli P, Guerra B, Landini MP. 1999. Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection. Clin. Diagn. Lab. Immunol. 6:127-129. (Pubitemid 29035651)
4. Lazzarotto T, Guerra B, Lanari M, Gabrielli L, Landini MP. 2008. New advances in the diagnosis of congenital cytomegalovirus infection. J. Clin. Virol. 41:192-197. http://dx.doi.org/10.1016/j.jcv.2007.10.015. (Pubitemid 351246738)
5. Revello MG, Fabbri E, Furione M, Zavattoni M, Lilleri D, Tassis B, Quarenghi A, Cena C, Arossa A, Montanari L, Rognoni V, Spinillo A, Gerna G. 2011. Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience. J. Clin. Virol. 50:303-307. http://dx.doi.org/10.1016/j.jcv.2010.12. 012.
6. Bodéus M, Feyder S, Goubau P. 1998. Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women. Clin. Diagn. Virol. 9:9-16. http://dx.doi.org/10.1016/S0928-0197(97) 10016-2. (Pubitemid 28153242)
7. Grangeot-Keros L, Mayaux MJ, Lebon P, Freymuth F, Eugene G, Stricker R, Dussaix E. 1997. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J. Infect. Dis. 175:944-946. http://dx.doi.org/10.1086/513996. (Pubitemid 27142973)
8. Dollard SC, Grosse SD, Ross DS. 2007. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev. Med. Virol. 17:355-363. http://dx.doi.org/10. 1002/rmv.544. (Pubitemid 47425872)
9. Lazzarotto T, Varani S, Spezzacatena P, Pradelli P, Potena L, Lombardi A, Ghisetti V, Gabrielli L, Abate DA, Magelli C, Landini MP. 1998. Delayed acquisition of high-avidity anti-cytomegalovirus antibody is correlated with prolonged antigenemia in solid organ transplant recipients. J. Infect. Dis. 178:1145-1149. http://dx.doi.org/10.1086/515671. (Pubitemid 28452211)
10. Lutz E, Ward KN, Gray JJ. 1994. Maturation of antibody avidity after primary human cytomegalovirus infection is delayed in immunosuppressed solid organ transplant patients. J. Med. Virol. 44:317-322. http://dx.doi.org/10.1002/ jmv.1890440402.
11. de Souza S, Bonon SH, Costa SC, Rossi CL. 2003. Evaluation of an in-house specific immunoglobulin G (IgG) avidity ELISA for distinguishing recent primary from long-term human cytomegalovirus (HCMV) infection. Rev. Inst. Med. Trop. São Paulo 45:323-326. http://dx.doi.org/10.1590/S0036-46652003000600005.
12. Munro SC, Hall B, Whybin LR, Leader L, Robertson P, Maine GT, Rawlinson WD. 2005. Diagnosis of and screening for cytomegalovirus infection in pregnant women. J. Clin. Microbiol. 43:4713-4718. http://dx.doi.org/10.1128/JCM.43.9. 4713-4718.2005. (Pubitemid 41298268)
13. Enders G, Daiminger A, Bader U, Exler S, Schimpf Y, Enders M. 2013. The value of CMV IgG avidity and immunoblot for timing the onset of primaryCMVinfection in pregnancy. J. Clin. Virol. 56:102-107. http://dx.doi.org/10.1016/j.jcv.2012.09.015.
14. Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP. 2000. Prenatal indicators of congenital cytomegalovirus infection. J. Pediatr. 137:90-95. http://dx.doi.org/10.1067/mpd.2000.107110. (Pubitemid 30470929)
15. Prince HE, Leber AL. 2002. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels. Clin. Diagn. Lab. Immunol. 9:824-827. http://dx.doi.org/10. 1128/CDLI.9.4.824-827.2002. (Pubitemid 34773885)
16. Lagrou K, Bodeus M, Van Ranst M, Goubau P. 2009. Evaluation of the new Architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays. J. Clin. Microbiol. 47:1695-1699. http://dx.doi.org/10.1128/JCM.02172-08.
17. Revello MG, Genini E, Gorini G, Klersy C, Piralla A, Gerna G. 2010. Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays. J. Clin. Virol. 48:255-259. http://dx.doi.org/10.1016/j.jcv.2010.05.004.
18. Carlier P, Harika N, Bailly R, Vranken G. 2010. Laboratory evaluation of the new Access cytomegalovirus immunoglobulin M and IgG assays. J. Clin. Virol. 49:192-197. http://dx.doi.org/10.1016/j.jcv.2010.07.024.
19. Vauloup-Fellous C, Berth M, Heskia F, Dugua J-M, Grangeot-Keros L. 2013. Re-evaluation of the VIDAS cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation. J. Clin. Virol. 56:118-123. http://dx.doi.org/10.1016/j.jcv.2012.10. 017.
20. Owen WE, Martins TB, Litwin CM, Roberts WL. 2006. Performance characteristics of six IMMULITE 2000TORCHassays. Am. J. Clin. Pathol. 126:900-905. http://dx.doi.org/10.1309/KUA926D3YAPFYQG8. (Pubitemid 44901843)
21. Binnicker MJ, Jespersen DJ, Harring JA. 2010. Multiplex detection of IgM and IgG class antibodies to Toxoplasma gondii, rubella virus, and cytomegalovirus using a novel multiplex flow immunoassay. Clin. Vaccine Immunol. 17:1734-1738. http://dx.doi.org/10.1128/CVI.00332-10.
22. Coll O, Benoist G, Ville Y, Weisman LE, Botet F, Anceschi MM, Greenough A, Gibbs RS, Carbonell-Estrany X, WAPM Perinatal Infections Working Group. 2009. Guidelines on CMV congenital infection. J. Perinat. Med. 37:433-445. http://dx.doi.org/10.1515/JPM.2009.127.
23. Macé M, Sissoeff L, Rudent A, Grangeot-Keros L. 2004. A serological testing algorithm for the diagnosis of primary CMV infection in pregnant women. Prenat. Diagn. 24:861-863. http://dx.doi.org/10.1002/pd.1001. (Pubitemid 39576798)
24. Dollard SC, Staras SAS, Amin MM, Schmid DS, Cannon MJ. 2011. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clin. Vaccine Immunol. 18:1895-1899. http://dx.doi.org/10.1128/CVI.05228-11.
25. Lazzarotto T, Galli C, Pulvirenti R, Rescaldani R, Vezzo R, La Gioia A, Martinelli C, La Rocca S, Agresti G, Grillner L, Nordin M, van Ranst M, Combs B, Maine GT, Landini MP. 2001. Evaluation of the Abbot AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay. Clin. Diagn. Lab. Immunol. 8:196-198. http://dx.doi.org/10. 1128/CDLI.8.1.196-198.2001. (Pubitemid 32065677)
26. Prince HE, Lapé-Nixon M, Brenner A, Jespersen D, Pitstick N, Couturier MR. 2014. Potential impact of different cytomegalovirus immunoglobulin M (CMV IgM) assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity. Clin. Vaccine Immunol. 21:813-816. http://dx.doi.org/10.1128/CVI.00106-14.